An observational study in Meningitis, Children, Only and Pneumococcal Conjugate Vaccine, sponsored by Association Clinique Thérapeutique Infantile du val de Marne. Recruiting at 1 site in France. Open to participants aged 1 Day to 18 Years. Per ClinicalTrials.gov, last updated 2026-04-28.
Sponsored by Association Clinique Thérapeutique Infantile du val de Marne · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Meningitis with a site in France — 3 open to participants now, 3 under way, none of them phase 3. Meningitis · France.
Among the 19 studies in Meningitis with a site in France, this one is the only one that started in 2001, is one of 8 observational ones, and was the 14th registered.
268 studies on the registry are indexed under Meningitis; 28 are open to participants now.
Browse Meningitis studies →3 of the 19 studies in Meningitis with a site in France are open now. Recruiting first, the newest first:
University Hospital, Strasbourg, France · Sites in France
Ages 18+ · Healthy volunteers
Central Hospital, Nancy, France · Sites in France
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 17 Meningitis studies recruiting now, 11 (65%) set no upper age limit and 6 (35%) stop at 75 or younger; 7 take children under 18; 2 take healthy volunteers.
This study: 1 Day to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2001.
This study's planned enrollment of 10,000 is above the median of 535 across 64 observational studies indexed under Meningitis.
Median enrollment 151 across the 11 interventional studies, 390 across the 8 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 19 have an industry lead sponsor. The 10 most frequent:
Association Clinique Thérapeutique Infantile du val de Marne is the lead sponsor of 15 studies on the registry; 11 are open to participants now.
Association Clinique Thérapeutique Infantile du val de Marne has 1 study filed under Meningitis — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 19 studies in Meningitis with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.
For children under 18, hospitalized for bacterial meningitis, the following data will be analyzed: risk factors, vaccination status, signs of symptoms, treatment during hospitalization, analysis (cerebrospinal fluid culture, cerebrospinal fluid antigen test, blood culture...), symptoms or clinic signs of illness.
children 0 day to 18 years with bacterial meningitis or purpura fulminans
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
mortality
Number of death according to age and bacteria
Time frame: before the hospital discharge
treatment failures
Number of antibiotic treatment failures according to bacteria after the control of lumbar puncture
Time frame: 48 hours after the antibiotic treatment and new lumbar puncture
impact of vaccines
Number of vaccination failures according to age, number of doses and bacteria
Time frame: before the hospital discharge
Plan to share: Undecided
Started Jan 2001 (actual). Primary completion is estimated for Jan 2030, 348 months after the start.
Of 29 observational studies under Meningitis, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 96. This study's planned 348 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Association Clinique Thérapeutique Infantile du val de Marne